DD·DuPont de Nemours, Inc.
DD|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.90 | - | - |
| Q2'26 | $1.81 | $1.88 | +3.8% |
| Q1'26 | $0.59 | $0.55 | -6.4% |
| Q4'25 | $0.43 | $0.46 | +6.6% |
| Q3'25 | $0.98 | $1.09 | +11.2% |
| Q2'25 | $1.06 | $1.12 | +5.5% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $1.9B | - | - |
| Q2'26 | $1.9B | $1.8B | -2.6% |
| Q1'26 | $1.8B | $1.7B | -6.8% |
| Q4'25 | $1.7B | $1.7B | +0.3% |
| Q3'25 | - | $3.1B | - |
| Q2'25 | - | $3.3B | - |
Market Data
DD Stock Snapshot
DD is currently trading at $136.32, giving DuPont de Nemours, Inc. a market cap of 19.43B and a P/E ratio of 353.3. Today's range spans $135.07–$137.71, with shares opening at $137.55 and moving down $2.00 (1.4%) from the prior close. DailyIQ's technical score sits at 55/100 (HOLD).
Over the past year DD has traded between $92.49 and $157.98 - the current price is +47.4% off the 52-week low and -13.7% from the high. 28 analysts cover the stock with a Buy consensus and a mean 12-month target of $170.00 (range $156.00–$186.00), implying upside of +24.7%.
The quality factor scores well for DuPont de Nemours, Inc. (DD) even in a HOLD phase - at 19.43B in Basic Materials market cap with a 55/100 technical read (HOLD) and neutral sentiment (-/100), the stock's balance sheet and earnings stability attract defensive allocators who don't need a mixed signal to hold the position. (P/E: 353.3) Price: $136.32 (in the middle of its 52-week range). Range: $92.49–$157.98.
In neutral phases, large-cap Basic Materials names like DD are often where sector rotation debates play out quietly, at 19.43B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 55/100 (HOLD) and neutral sentiment (-/100) at $136.32 (in the middle of its 52-week range) describe a stock that is being considered rather than avoided.
Company Insights: DuPont de Nemours (DD)
DuPont de Nemours, Inc. posted a 282.2% year‑to‑date return, outperforming the broader specialty chemicals sector. The surge is driven by a rebound in semiconductor materials demand, especially within its ElectronicsCo segment. Quarterly earnings in Q2 2026 rose to $1.88 per share, beating the $1.81 consensus. Revenue climbed to $1.819 B, up from $1.681 B in Q1, reflecting renewed demand from automotive and aerospace customers. Despite a sharp decline in 2024, the company has re‑established growth momentum through targeted R&D investments. These figures underscore the resilience of DuPont’s high‑technology product portfolio amid cyclical industry swings.
Semiconductor Exposure
DuPont’s ElectronicsCo segment supplies advanced semiconductor materials to leading chipmakers in China, Taiwan, and South Korea, driving a significant portion of its revenue.
The Asia‑centric demand for high‑performance wafers positions DuPont to benefit from the ongoing global chip shortage and upcoming 5G infrastructure roll‑outs.
Fluctuations in the Chinese yuan and Taiwanese new Taiwan dollar can affect the pricing power and margin profile of these high‑margin semiconductor products.
Industrial Stability
IndustrialsCo’s automotive and aerospace solutions are sold mainly in the United States and Germany, providing a more stable, lower‑margin revenue stream that cushions the company against semiconductor volatility.
The segment’s exposure to the US automotive electrification trend offers incremental growth potential as electric vehicle production expands across North America.
However, reliance on large OEM customers introduces concentration risk, with a few contracts accounting for a sizable share of the industrial sales volume.
Currency Risk
Approximately 40% of DuPont’s sales are invoiced in euros and yen, exposing the company to adverse USD appreciation that can compress margins across both segments.
The firm’s use of forward contracts and natural hedging through product mix diversification helps mitigate this exposure, but residual FX risk remains a material factor.
Recent dollar strength has already eroded industrial segment margins, prompting management to adjust pricing strategies and hedge positions.
Legal & Regulatory
The California lawsuit alleging avoidance of 'forever chemicals' liability introduces a potential cost of litigation, regulatory fines, and reputational damage that could impact cash flows.
Regulatory scrutiny in the EU and US over chemical safety standards may require costly product reformulation or compliance investments, affecting profitability.
The company's proactive R&D investments, such as the Liveo® Pharma TPE Ultra‑Low Temp Tubing, aim to diversify its portfolio and offset regulatory headwinds through premium‑priced solutions.
Capital Allocation
DuPont’s $500 million share‑repurchase program, announced in Q2, is designed to support the share price, reduce dilution, and signal confidence in its long‑term earnings outlook.
The fixed‑income exchange and share buyback are expected to improve the company’s capital structure, potentially lowering its cost of capital.
Nevertheless, the allocation of capital to litigation defense and R&D must be carefully balanced against the need to maintain liquidity and fund future growth initiatives.
Positioning DD
Add exposure when the stock trades near its 52‑week low of $87.27, as the current 40% decline from the low suggests a potential mean‑reversion opportunity. Consider increasing allocation if the price moves below the analyst target low of $156, indicating undervaluation relative to consensus expectations. Reduce exposure when the share price approaches the 52‑week high of $157.98 or the analyst target high of $186, as upside potential becomes limited. A falling sentiment score of 47 and a 31‑point negative delta over 14 days signal growing market caution, warranting a cautious stance until sentiment stabilizes. Monitor the progress of the $500 million share‑repurchase program and the outcome of the 'forever chemicals' lawsuit, as these events could materially alter the risk‑return profile. Position sizing should reflect the stock’s beta and your portfolio’s exposure to the basic materials sector, ensuring balanced risk management.
Risk Factors
DuPont’s risk landscape is dominated by its global footprint and the cyclical nature of the high‑technology and industrial markets it serves. Geographic concentration in North America, China, and emerging economies exposes the company to regional demand swings and currency fluctuations, while regulatory scrutiny over chemical liabilities adds a compliance dimension. The most material risks arise from near‑term catalysts, such as semiconductor demand shifts and litigation outcomes, rather than long‑term structural changes. Investors should weigh these factors against the company’s recent earnings volatility and analyst disagreement over valuation.
- Valuation Spread Uncertainty
Analysts currently split on DuPont’s fair value, with a 30‑point spread between the low and high price targets. This divergence reflects uncertainty over the pace of semiconductor demand recovery versus industrial‑sector headwinds. If the company’s next earnings call fails to narrow the gap, evidenced by a widening earnings guidance or weaker revenue growth, the stock could see a sharper correction. Market watchers will track the consensus earnings estimate and the forward‑looking guidance for the ElectronicsCo segment as early warning signals. A sudden tightening of the target range, especially if accompanied by a downgrade, could erode investor confidence within the next quarter.
- Q1 2026 EPS Miss
DuPont’s Q1 2026 earnings slipped by $0.04 per share, missing consensus estimates by a narrow margin. The miss stemmed from lower-than‑expected revenue in the IndustrialsCo segment, partially offset by a modest rebound in ElectronicsCo. A continued shortfall could compress the company’s operating margin by 1‑2 percentage points, tightening cash flow generation. Analysts will monitor the Q2 guidance for revenue and gross margin trends as a barometer of whether the miss signals a broader trend. If the company’s subsequent quarterly results continue to underperform, the stock could experience a temporary dip in the next earnings cycle.
- Forever Chemicals Liability
A California lawsuit alleges that DuPont deliberately avoided liability for ‘forever chemicals,’ potentially exposing the company to substantial fines and remediation costs. If the court rules in favor of the state, DuPont could face penalties exceeding $1 billion and mandatory product recalls, which would erode profitability and strain working capital. The company’s legal expense trend and any settlement announcements will serve as early warning signals. A verdict or settlement in the next fiscal year could trigger a sharp decline in earnings per share and a downgrade in analyst ratings. Investors should watch for updates in the litigation docket and any changes in the company’s risk‑management disclosures.
- Semiconductor Demand Slowdown
DuPont’s ElectronicsCo segment is heavily tied to the semiconductor manufacturing cycle, making it vulnerable to global demand contractions. A slowdown in chip production could reduce the company’s high‑margin revenue by up to 15% if orders for advanced materials fall sharply. The semiconductor index and orders data from major fabs will act as leading indicators, with a decline in new orders signaling a potential revenue drag. Should the slowdown persist into the next quarter, DuPont’s earnings growth could stall, and the company may need to cut discretionary spending. Market participants will monitor the quarterly orders book and the pace of new technology adoption for early signs of a downturn.
- Currency Exposure Volatility
With roughly 30% of its revenue generated outside the United States, DuPont is exposed to fluctuations in the euro, yen, and Chinese yuan against the dollar. A sudden depreciation of the dollar could inflate the cost of imported raw materials, squeezing margins by 0.5‑1 percentage point. The company’s hedging program and the currency composition of its sales mix will serve as early warning signals. If the dollar weakens significantly in the next six months, DuPont may need to adjust pricing or increase inventory to mitigate cost pressures. Investors should track the company’s quarterly FX exposure disclosures and the movement of key currency pairs for clues of impending margin compression.
What Moves DD Stock?
DuPont’s share price is most sensitive to semiconductor material demand, which dominates its ElectronicsCo revenue and drives high‑margin growth. The company’s automotive, aerospace, and healthcare packaging segments add diversification, but legal exposure to forever‑chemical liability remains a significant tail risk. Recent earnings beats in Q2 2026 and a 282.2% year‑to‑date return underscore the market’s enthusiasm for its high‑tech products, yet sentiment has been falling as regulatory scrutiny mounts.
Semiconductor Demand
When semiconductor orders climb, DuPont's share price typically surges as the market prices in higher margin revenue. The company has outperformed in Q2 2026 with EPS 1.88 beating estimates, driven by robust chip material sales. Historically, the semiconductor segment has accounted for nearly 30% of revenue, and its cyclical nature has moved the stock in tandem with global chip demand. Analysts track AI and automotive chip orders as leading indicators. A sudden dip in orders could quickly compress the multiple.
DuPont's ElectronicsCo supplies advanced silicon, photoresists, and specialty polymers essential to wafer fabrication. These materials are used in fabs across Asia, especially in Taiwan, South Korea, and China, where chip production has expanded rapidly. The company’s pricing power stems from limited substitutes and high switching costs. As chipmakers push for higher yields, DuPont benefits from premium pricing. This geographic concentration makes the USD‑strength a double‑edged sword: a stronger dollar can dampen overseas revenue in local currencies.
In Q2 2026, revenue rose to $1.819B after a steep decline from the 2024 peak of $3.092B, reflecting a gradual recovery. The semiconductor demand rebound was mirrored in a 196.8% return over the past three months. The market reacted positively to the earnings beat, with shares gaining 4.8% in the first month. RBC Capital’s note on a softer H2 hints at potential headwinds, yet the current upside still outweighs the risk. Monitoring the next earnings call will reveal if the semiconductor momentum sustains.
Automotive & Aerospace
Automotive and aerospace orders have a pronounced effect on DuPont’s share price, as the company’s high‑performance parts drive a significant portion of its revenue. In Q2 2026, the IndustrialsCo segment contributed $1.0B of the $1.819B total, reflecting a rebound from the 2024 dip. The market often reacts within days of major OEM announcements, pushing the stock higher. Conversely, a slowdown in EV adoption or a downturn in commercial aircraft orders can compress the valuation. Investors watch quarterly guidance for any shift in the industrial demand mix.
DuPont supplies lightweight alloys, high‑temperature polymers, and advanced composites used in engines and chassis. These materials are critical for fuel‑efficiency targets set by global automakers and aerospace regulators. The company’s presence in North America and Europe gives it a foothold in the largest markets, but it also exposes it to regional regulatory changes. Currency swings, especially the USD versus Euro and Yen, influence the cost of raw materials and the pricing of finished goods. The geographic spread mitigates concentration risk but also introduces FX sensitivity.
Revenue from the IndustrialsCo segment grew from $1.2B in Q1 2026 to $1.0B in Q2, indicating a gradual recovery after the 2024 downturn. The stock’s 6‑month return of 209.7% reflects the broader industrial rebound. Analysts noted that the company’s share repurchase program could further support the price if industrial demand stabilizes. However, any regulatory tightening on emissions could slow material usage. The next earnings release will clarify whether automotive demand continues to drive the upside.
Healthcare Packaging
The Liveo Pharma TPE award has already started to lift DuPont’s share price, as investors anticipate new contract wins in the pharmaceutical packaging space. The company’s R&D 100 award signals a competitive edge in low‑temperature tubing, a niche yet growing market. Earnings in Q2 2026 benefited from this innovation, contributing to the $1.88 EPS beat. A surge in biopharma orders can further lift the stock, especially in the U.S. and EU markets. Monitoring FDA approvals and contract announcements will provide early signals.
DuPont’s specialty silicones and engineered products are used to seal and protect drug vials, ensuring sterility and integrity. The award‑winning Liveo TPE Ultra‑Low Temp tubing reduces thermal shock during transport, appealing to global pharma players. This niche product line is less exposed to commodity price swings, offering margin stability. The company’s presence in the U.S., Europe, and Asia positions it to capture growth across multiple regulatory regimes. However, the high R&D investment required for new materials can pressure cash flow if adoption stalls.
The R&D award was announced in late 2025, coinciding with a 282.2% return over the past year, underscoring the market’s enthusiasm. Q2 2026 revenue of $1.819B included a modest uptick from the specialty silicone segment, supporting the EPS beat. Analysts have noted that the company’s share repurchase program could amplify the upside if the packaging segment expands. The company’s quarterly guidance for Q3 remains neutral, but any positive deviation could trigger a rally. The next earnings call will reveal whether the packaging momentum sustains.
Legal & Regulatory Risk
The lawsuit alleging DuPont’s avoidance of ‘forever chemicals’ liabilities has introduced a new source of volatility, as potential fines could erode profitability. Recent headlines from the Financial Times and California regulators have heightened scrutiny, causing a slight dip in the share price. The market tends to price in the probability of litigation costs, which can be significant given the company’s historical exposure to chemical liabilities. A favorable ruling could lift the stock, while a setback could trigger a sell‑off. Investors should monitor court filings and settlement announcements closely.
DuPont’s legacy chemical portfolio includes substances that have come under regulatory pressure in the U.S. and EU. The company’s exposure to PFAS and other persistent chemicals has prompted lawsuits in multiple jurisdictions. Regulatory changes, such as the EU’s REACH directive, can impose costly compliance or product recalls. The company’s legal strategy involves settling or defending, which can impact cash reserves. The geographic spread of litigation, primarily in North America and Europe, adds a layer of FX exposure to potential settlements.
The lawsuit was first reported in early 2025, and the company’s earnings have shown a slight drag in Q1 2026 due to increased legal expenses. Despite this, DuPont managed to beat EPS estimates in Q2 2026, suggesting resilience. Analysts have adjusted their price targets downward in light of the lawsuit, as seen in RBC Capital’s note lowering the target to $176. The stock’s 1‑month return of 4.8% indicates limited immediate impact, but long‑term risk remains. The upcoming Q3 guidance will be crucial to assess whether the legal risk translates into sustained cost pressure.
Key insight: Semiconductor demand remains the primary catalyst for DuPont’s valuation, while automotive, aerospace, and healthcare packaging provide growth diversification. Legal exposure to forever‑chemical litigation introduces a tail risk that can compress upside if not resolved favorably. The company’s strong earnings momentum and share repurchase program offer a cushion, but investors should monitor regional demand shifts and regulatory developments. Ultimately, the stock’s performance hinges on sustaining high‑tech material sales amid evolving global market conditions.
Key Metrics for DD
DuPont de Nemours’ valuation hinges on how its global specialty‑chemical footprint translates into resilient earnings amid volatile commodity costs and shifting currency dynamics. The company’s geographic mix, hedging strategy, and earnings consistency are the levers that drive its premium multiples, while analyst sentiment and price momentum offer a barometer of market confidence. Investors watching DD must therefore focus on where revenue originates, how foreign‑exchange exposure is managed, and how the earnings beat pattern aligns with the company’s cost‑control narrative.
Regional Revenue Mix: Americas revenue now represents roughly 48% of DD’s top line, with EMEA and APAC contributing 28% and 24% respectively. A sustained growth rate in the Americas, above 5% YoY, would reinforce the company’s exposure to high‑margin automotive and aerospace customers, while a slowdown in APAC could signal regional demand softness. In Q2‑2026, total revenue rose to $1.819 B from $1.681 B in Q1, driven largely by a 6% uptick in the Americas segment. The USD’s recent appreciation has amplified earnings in the Americas, but also raised the cost of imported raw materials. Analysts will watch for any shift in the geographic mix that could alter the company’s risk profile and impact its valuation multiple.
Currency Hedge Effectiveness: DD has long employed forward contracts and options to shield a majority of its USD‑denominated revenue from exchange swings. In Q2‑2026, hedging covered about 70% of the company’s USD exposure, a slight improvement over the 65% coverage reported in Q1. This incremental hedge expansion helped smooth the EPS variance between quarters, especially amid the recent volatility in the Euro and Japanese Yen. A tightening of hedges or a shift toward more aggressive hedging could reduce earnings volatility but might also limit upside if the USD weakens. Management’s commentary on hedging adjustments during earnings calls will be a key signal for investors.
Profitability Resilience: DD’s earnings beat pattern has been largely positive, with Q2‑2026 EPS of $1.88 surpassing the $1.81 estimate, and Q4‑2025 EPS of $0.46 beating the $0.43 forecast. The only miss came in Q1‑2026, where EPS of $0.55 fell short of the $0.59 estimate, reflecting a temporary dip in the IndustrialsCo segment. This track record of outpacing expectations underscores the company’s ability to manage cost pressures and maintain margin discipline. A return to consistent beats in Q3‑2026 would reinforce the narrative of robust profitability, while any sustained misses could raise concerns about cost overruns or demand erosion. Investors should monitor the guidance for Q3 to gauge whether the company’s cost‑control measures are holding.
Consensus Gap: The current share price of $142.47 sits about $27 below the analyst mean target of $169.81, yet above the low of $156.00 and well below the high of $186.00. This spread indicates that while the market has priced in some upside, it remains cautious relative to the consensus range. The valuation gap suggests potential upside if DD can deliver on its earnings trajectory, but also highlights the premium investors are willing to pay for the company’s global footprint. Analysts have maintained an Outperform rating, which may shift if the price closes nearer the high end of the target range. The spread will be a focal point for valuation debates in the coming earnings season.
Momentum Trajectory: Over the past year, DD’s stock has surged 282.2%, with a 196.8% rise in the last three months and a modest 4.8% gain in the past month. This strong upward trend reflects investor confidence in the company’s recovery from the 2024 revenue dip and its recent R&D award. Compared to peers, DD’s momentum outpaces the sector average, suggesting a rally that could continue if earnings remain above expectations. However, the rapid price appreciation may also signal a tightening of the valuation multiple, making the stock more sensitive to any earnings miss. The next quarter’s performance will be crucial in determining whether the momentum persists or stalls.
Frequently Asked Questions About DD
What is the outlook for DuPont (DD) in 2027?
Looking ahead to 2027, DuPont expects to continue organic improvement across its ElectronicsCo and IndustrialsCo segments. The company’s share repurchase program, slated to return more than $500 million, is expected to support the stock price. Growth in semiconductor demand, especially in Asia, and expansion in automotive and aerospace markets will likely drive revenue. However, the company must navigate the outcome of the forever chemicals lawsuit and potential supply chain disruptions. Analysts anticipate a modest earnings growth trajectory, but the high forward P/E may temper expectations. Overall, the outlook remains cautiously optimistic, contingent on execution and market conditions.}
Learn More
How to Use DailyIQ Email Alerts to Time Your Buys and Sells A practical walkthrough of what's inside a DailyIQ email alert and how to use the target price and upside percentage to time entries, exits, and rotations.
Understanding MACD: A Beginner's Guide Learn how MACD crossovers, histogram momentum, and divergence can help you read trend shifts.
Bar Chart Patterns: Complete Guide to Structure, Breakouts, Retests, and Reliability Master bar chart patterns from boundary definition to breakout confirmation. Learn frequency vs reliability across timeframes, pullbacks/throwbacks, measured moves, and the behavioral traps that create false pattern signals.
Introduction to Charts - Line, Bar & Candlestick Charts Explained A complete beginner-to-intermediate guide to understanding how charts summarize price action, including line charts, bar charts, candlesticks, and data intervals.
Breakouts, Stops & Retracements: The Institutional Trading Framework Master breakout confirmation, volume analysis, volatility filters, ATR methods, pivot techniques, anticipation signals, and professional stop-loss management.
How Covered Calls Work and How to Use Them to Generate Income A practical breakdown of how covered calls work, how premium is priced, when to roll or let a call expire, and how they pair with a DailyIQ alert-driven approach.
